Zynlonta Dosage & Drug Information

Information is sourced from publicly available references. The information is for educational purpose of healthcare professionals and we are not liable for any loss or damage.

Core Prescribing Info

Contents

Loncastuximab tesirine

Indications/Uses

Relapsed or refractory diffuse large B-cell lymphoma in adult patients after ≥2 lines of systemic therapy.

Dosage/Direction for Use

IV 0.15 mg/kg infusion over 30 min every 3 wk for 2 cycles. 0.075 mg/kg infusion over 30 min every 3 wk for subsequent cycles. Premed: Administer dexamethasone 4 mg PO or IV bd for 3 days beginning the day before Zynlonta administration. If dexamethasone does not begin the day before Zynlonta, administer dexamethasone at least 2 hr prior to Zynlonta.

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FX22 - loncastuximab tesirine ; Belongs to the class of other monoclonal antibodies and antibody drug conjugates. Used in the treatment of cancer.

Regulatory Classification

POM

Presentation/Packing

Form

Zynlonta powd for soln for inj 10 mg

Packing/Price

1's

Zynlonta

Manufacturer:

BSP Pharmaceuticals